Veryan Medical announced a multimillion-euro investment at its Galway facility to expand and diversify its product portfolio beyond the BioMimics 3D stent. The investment is expected to create 20 new jobs.
Otsuka Holdings Co., Ltd. announced a merger agreement to acquire the remaining shares of ReCor Medical, Inc. The transaction is subject to ReCor's shareholder approval.
Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings, completed the acquisition of Veryan Medical Ltd. through its UK subsidiary. Veryan's R&D operations in Galway, Ireland, will be retained.
Otsuka Holdings signed a merger agreement to acquire the remaining shares of ReCor Medical, which develops the Paradise Renal Denervation System for hypertension treatment.